# ANNOVIS BIO INC (ANVS)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/ANVS/

- Reporting holders: 2
- Reported value: $75.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Sherry Group, Inc.](https://holderbook.com/funds/2107738-sherry-group-inc/) | $72.7K | 57,270 | 0.1% | 4 |
| [CoreCap Advisors, LLC](https://holderbook.com/funds/1902501-corecap-advisors-llc/) | $2.7K | 2,101 | 0.0% | 3 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 2 | $75.4K |
| Q2 2026 | 65 | $24.5M |
| Q1 2026 | 58 | $12.0M |
| Q4 2025 | 55 | $17.4M |
| Q3 2025 | 42 | $4.9M |
| Q2 2025 | 42 | $4.5M |
| Q1 2025 | 46 | $3.6M |
| Q4 2024 | 42 | $13.3M |
| Q3 2024 | 38 | $24.8M |
| Q2 2024 | 44 | $29.8M |
| Q1 2024 | 43 | $52.2M |
| Q4 2023 | 41 | $26.3M |